Source: International Congress 2016 – GOLD: novel approaches to COPD assessment and management
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Leonardo Michele Fabbri (Modena, Italy). Evaluation and treatment of comorbidities. International Congress 2016 – GOLD: novel approaches to COPD assessment and management

Member's Comments

No comment yet.

Related content which might interest you: Screening for comorbidities inCOPD Source: Breathe, 16 (1) 190315; 10.1183/20734735.0315-2019 Year: 2020 Comparison of comorbidities between two different subgroups in combined assessment of COPD Source: International Congress 2016 – Postural balance, respiratory muscles, and comorbidities in chronic respiratory disease Year: 2016 Treatment strategies for patients with complex chronic comorbidities Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006 Effect of comorbidities on severity and clinical parameters of COPD Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Prevalence of comorbidities and impact on pulmonary rehabilitation outcomes Source: ERJ Open Res, 5 (4) 00264-2019; 10.1183/23120541.00264-2019 Year: 2019 Impact of diabetes mellitus on clinical parameters and treatment outcomes of diagnosed pulmonary tuberculosis patients Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014 Effectiveness of rehabilitation in COPD outpatients with comorbidities Source: Annual Congress 2009 - Are outcome measures useful to predict success in rehabilitation and the care of patients with chronic respiratory disease Year: 2009 Clinical management improves the treatment outcome of MDR-TB patients Source: International Congress 2017 – Paediatric TB: MDRTB (II) Year: 2017 Impact of comorbidities and delay in diagnosis in elderly patients with pulmonary hypertension Source: ERJ Open Res, 4 (4) 00100-2018; 10.1183/23120541.00100-2018 Year: 2018 Pharmacological treatment of self-reported cardiovascular comorbidity in COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 453s Year: 2007 Evaluation of methotrexate in the treatment of severe asthma Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 Quantify comorbidities burden of chronic obstructive pulmonary disease patients using medication regimen complexity index Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Efficacy of using special software “Optimization of medication choice for treatment of patient with comorbidity” (SS) for management of patients with community-acquired pneumonia (CAP) and cardiovascular disease Source: International Congress 2019 – M-health/e-health I Year: 2019 Other comorbidities Source: Eur Respir Monogr 2016; 71: 186-195 Year: 2016 Clinical characteristics and treatment outcomes of tuberculosis in the elderly Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012 Assessment of patient status and treatment goals Source: Annual Congress 2009 - Pulmonary hypertension – recent progress in research and practice Year: 2009 Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis in an endemic area Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II Year: 2013 Impact Prognostic impact of comorbidities in patients with chronic Hypersensitivity Pneumonitis Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside Year: 2018 Risk factors for anti-tuberculosis treatment failure Source: Annual Congress 2011 - Tuberculosis epidemiology and public health Year: 2011